Stockholm3, a prostate cancer test developed in Sweden, runs a combination of protein and genetic markers from a blood sample through an algorithm to find the probability of a patient having clinically significant cancer.
Study validates Stockholm3 test for prostate cancer in ethnically mixed populations
- Post author:
- Post published:July 23, 2024
- Post category:uncategorized